Has Sheila Hamilton, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $5,438 in general payments to Sheila Hamilton, APRN across 167 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sheila Hamilton, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sheila Hamilton, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sheila Hamilton, APRN

Acute Care · Tulsa, OKNPI 1639410764

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,259 of the $5,438 with a category attached, or 78.3%. 30 manufacturers reported payments, led by Atricure, Inc. at 41.7% of the total. Reporting peaked in 2024 at $2,181 and has fallen 57.1% since, to $935 in 2025. Among acute care clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,438in general payments, 2019–2025

Across 167 payments — averaging $32.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$2K
Medtronic$680
Abiomed$279
Novo Nordisk$249
Johnson & Johnson$245
W. L. Gore & Associates, Inc.$245
plus $1K from 24 others

What the payments were for

Travel & lodging$1,09020%
Food & beverage$4,25978%
Education$892%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	20	$2,268
Medtronic	36	$680
Abiomed	9	$279
Novo Nordisk	12	$249
Johnson & Johnson(3 entities)	14	$245
W. L. Gore & Associates, Inc.	9	$245
Baxter Healthcare	9	$206
Bolton Medical Inc	10	$205
Chiesi USA, Inc.	12	$182
Actelion Pharmaceuticals US, Inc.	2	$110
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$100
Nuwellis, Inc.	2	$75
La Jolla Pharmaceutical Company	1	$69
BD	1	$60
Polynovo North America LLC	2	$53
Pacira Pharmaceuticals Incorporated	2	$51
KCI USA, Inc.	3	$46
Silk Road Medical, Inc.	1	$36
Solventum Corporation	2	$32
Endologix LLC	1	$31
Edwards Lifesciences	2	$31
Getinge USA Sales, LLC	2	$30
Acera Surgical, Inc.	1	$29
Cvrx, Inc.	1	$21
Teleflex LLC	1	$20
Grifols USA, LLC	1	$19
Viz.ai, Inc.	1	$19
Convatec Inc.	1	$18
Terumo Medical Corporation	1	$15
Surmodics, Inc.	2	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,438 in reported general payments places this provider in the 90th percentile of 266 acute care providers in Oklahoma.

See all acute care providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$4,858

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	14	$10,421
Amiodarone Hcl	43	$450
Atorvastatin Calcium	36	$418
Potassium Chloride	35	$367
Metoprolol Tartrate	90	$336
Gabapentin	22	$186
ClopidogrelClopidogrel Bisulfate	28	$171
Spironolactone	11	$84
Amlodipine Besylate	14	$83
Furosemide	32	$79
Carvedilol	11	$40

Paid to pharmacies, not to this prescriber.

Other acute care in Tulsa

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →